Cargando…
Recombinant FSH Compared to Clomiphene Citrate as the First-Line in Ovulation Induction in Polycystic Ovary Syndrome Using Newly Designed Pens: A Randomized Controlled Trial
Objective: Since there is still controversy regarding the best first-line choice for ovulation induction (OI) other than clomiphene citrate (CC) in infertile women diagnosed with polycystic ovary syndrome (PCOS), the aim of the present study was to compare recombinant human FSH with CC as the first...
Autores principales: | Hossein-Rashidi, Batool, Khandzad, Bahareh, Shahrokh-Tehraninejad, Ensieh, Bagheri, Maryam, Gorginzadeh, Mansoureh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930453/ https://www.ncbi.nlm.nih.gov/pubmed/27385973 |
Ejemplares similares
-
Letrozole is superior to clomiphene citrate in ovulation induction in patients with polycystic ovary syndrome
por: Sakar, Mehmet Nafi, et al.
Publicado: (2020) -
Sildenafil citrate as an adjuvant to clomiphene citrate for ovulation induction in polycystic ovary syndrome: crossover randomized controlled trial
por: Mohammed, Walid E., et al.
Publicado: (2022) -
The significance of anthropometric and endocrine parameters in ovulation induction with clomiphene citrate in women with polycystic ovary syndrome
por: Akpinar, Funda, et al.
Publicado: (2016) -
Controlled ovarian stimulation with r-FSH plus r-LH vs. HMG plus r-FSH in patients candidate for IVF/ICSI cycles: An RCT
por: Shahrokh Tehraninejad, Ensieh, et al.
Publicado: (2017) -
The Effect of Insulin Resistance on Ovulation Induction With Clomiphene Citrate in Non-polycystic Ovary Syndrome (PCOS) Women
por: Karnatak, Ruchi, et al.
Publicado: (2022)